Santo “Sandy” Costa has been Of Counsel in the life sciences practice at the law firm Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP since August 2007. Prior to joining Smith Anderson, he was Of Counsel at the law firm William Mullen Maupin Taylor, P.A from June 2001 to August 2007. Mr. Costa previously held several positions with Quintiles Transnational Corp., including President and Chief Operating Officer and Vice-Chairman. Prior to joining Quintiles, Mr. Costa spent 23 years in the pharmaceutical industry, most recently as Senior Vice President, Administration and General Counsel of Glaxo Inc. where he also sat on the company's board of directors. In addition, Mr. Costa sits on the board of directors of CV Therapeutics Inc., Labopharm Inc. and DigiScripts, Inc. Mr. Costa is an adjunct professor in the clinical research program at the Campbell University School of Pharmacy. He also sits on the Duke Cancer Patient Support Program Advisory Board, the Duke University Medical Center Board of Visitors, and the Duke Brain Tumor Advisory Board. Mr. Costa received his B.S. in pharmacy and his J.D. from St. John's University. Mr. Costa has been a member of our Board of Directors since June 2006 and Chairman of our Compensation Committee since November 2006.